Engineering and technology

INTERCEPT Open Market Consultation: Innovation Procurement of Advanced Technologies for Safe Remote Vehicle Stopping

  INTERCEPT Open Market Consultation INTERCEPT is a project focused on identifying and supporting the development of innovative, safe, and effective technologies for remotely stopping vehicles. The project addresses a critical public safety need: preventing the misuse of vehicles for hostile purposes and enhancing the capabilities of European law enforcement authorities by providing them with effective and safe means to remotely stop vehicles that pose imminent and high-security threats to citizens and society. Through INTERCEPT, a group of public authorities will collaborate to jointly procure research and development services aimed at tackling this shared challenge. The solutions will be selected through a competitive PCP process and must address the challenges related to vehicle-stopping scenarios identified by the public buyers.   Join the INTERCEPT OMC Event! An OMC Event will take place to present the current challenge and engage in dialogue with market players. 📅 Date: 25 June 2025 📍 Location: Warsaw - participation is free of charge 💡  More information & registration: https://intercept-horizon.eu/update/ We also invite interested parties to register your solution via the Call for Interest and participate in the OMC to shape the upcoming tender: Open Market Consultations. The SPIN4EIC consortium is not responsible for the challenges launched by private or public buyers. Each participating entity is solely responsible for its own challenge, including the selection process, communication with applicants, and all information provided to participants. If you are interested in receiving detailed information and support by the SPIN4EIC Team on this opportunity, please do not hesitate to contact us by submitting the Application questionnaire.

Challenge: Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device by HaDEA

Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device Health and Digital Executive Agency (HaDEA) About  The Health and Digital Executive Agency (HaDEA) has issued a tender within the context of the EU4Health Annual Work Programme 2024.  EU4Health is the fourth and largest of the EU health programmes, providing funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe HaDEA manages the vast majority of the total EU4Health budget and implements the programme by managing calls for proposals and tenders from 2021 to 2027.   The Challenge   This challenge aims to accelerate the development of innovative point-of-care diagnostic devices capable of delivering antimicrobial susceptibility testing (AST) results within one hour or less from sample collection. The envisioned solutions should also ideally enable simultaneous pathogen identification, with a focus on at least one of the bacteria included in the 2024 WHO bacterial pathogen priority list and/or the fungi Candida spp. and Aspergillus fumigatus. This call also supports the advancement of promising rapid AST technologies currently under development, with the overarching goal of enhancing timely clinical decision-making and addressing the growing threat of antimicrobial resistance.   Timeframe Deadline to apply for Step 1 of the procedure: 12 May 2025, 16:00 CEST. Invitations to submit an offer for Step 2 will be indicatively sent out at the beginning of June, with a deadline for step 2 indicatively in early September.  Who can apply  

• Applicants with solutions of TRL 3-8, with a clear pathway for CE marking in the EU19. By the end of the contract, the product developed should aim at reaching system complete and qualified (TRL 8).

  How to apply  Interested parties are invited to apply on the Funding and Tenders Portal.  Find here all the details of the procedure. The SPIN4EIC consortium is not responsible for the challenges launched by private or public buyers. Each participating entity is solely responsible for its own challenge, including the selection process, communication with applicants, and all information provided to participants.